TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

189.70$ -0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Repligen Corporation (RGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 117 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RGEN
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-3.2 -0.7 -1.2 -3.1 -4.6 -4.8 -5.3 -5.7 -0.8 0.4 0.4 38 6.3 -2.4 3.2 2.3 13 26 18 15 7.5 17 33 67 63 119 172 114 175 117
0.2 0.2 0.3 0.3 0.3 0.3 0.8 0.9 0.8 0.4 0.5 0.8 1.1 1.4 1.7 1.3 3.5 3.1 4.0 4.6 5.3 11 16 21 27 38 57 68 87 97
– – – – – – – 24 24 21 524 524 0.8 1.0 1.0 – 1.0 1.1 1.8 3.6 4.6 6.7 10 13 17 28 27 26 48 33
– – – – – – – – – – – – – – – – -1.5 3.9 4.2 7.6 3.7 -18 10 19 13 35 26 – – –
-3.4 -0.2 0.1 0.2 0.0 -0.6 -1.6 0.4 1.4 -0.8 -0.1 -0.3 -1.3 -0.8 0.6 -12 -2.4 2.8 2.0 -6.5 -16 -7.5 -14 -2.6 -49 -102 -70 -8.6 61 -51
0.4 0.1 0.3 0.2 0.2 0.3 1.1 0.3 0.1 0.7 1.3 1.1 1.3 0.6 0.5 575 1.3 4.6 5.6 2.6 4.3 5.5 14 23 26 67 133 39 33 24
-0.2 – -0.3 -9.0 -5.1 -2.7 2.7 -8.4 0.0 1.5 1.8 -14 -32 9.9 -1.5 -5.0 2.8 -18 -20 4.8 -49 -98 -14 -205 -201 -221 -233 – -86 -298
– – – – – – – – – – – – – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 0.5 – 2.9 17 566 – –
– – – – – – – – – – – -2.0 -2.0 – – -0.3 1.2 2.5 1.7 0.9 1.8 132 3.4 -0.5 0.0 -2.9 -17 -14 -14 0.0
– – – – – – – – – – – – – – – – – – 111 111 111 0.0 0.0 163 0.0 0.0 0.0 290 -70 0.0
– 2.0 – 34 0.7 0.0 – 12 0.0 0.3 0.1 0.6 -1.6 0.0 -0.1 -0.3 1.2 2.5 1.7 0.8 112 130 3.4 485 306 1.0 -13 249 -83 -15
-3.4 1.3 -1.5 22 -9.1 -7.5 -2.6 -2.1 -0.7 2.2 2.3 25 -28 7.5 1.7 -3.0 18 11 -4.5 19 68 52 20 344 180 -113 -80 228 6.0 -191
-3.6 -0.8 -1.5 -3.4 -4.8 -5.1 -6.3 -6.0 -0.8 -0.3 -0.9 37 5.0 -3.0 2.7 1.7 12 21 13 12 3.2 12 19 44 36 52 39 75 142 94

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?